Propolis Containing Chewing Gum and Gingivitis
Launched by NAKSAKA · Nov 11, 2024
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
Plaque is the primary etiological factor of periodontal diseases and as a result, inflammation of the gingiva can clinically lead to irreversible consequences such as bone and attachment loss and even tooth loss. Removing the plaque is the most important criterion in preventing inflammation. Plaque should be removed by brushing and the use of interface cleansing agents such as dental floss. However, it has been reported in studies that manually brushing teeth reduces plaque by 70%.
Propolis, which has anti-inflammatory effects, has been used for years in the treatment of infections and wou...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Systemically healthy
- • Has at least 20 teeth in his/her mouth.
- Exclusion Criteria:
- • Smokers
- • ongoing orthodontic treatment
- • Allergy to the honey and honey-bee products
- • periodontal therapy in the last 6 months.
- • Pregnancy and breastfeeding
- • Use of antibiotics or another drugs in the last three months,
- • Presence of subgingival caries or infection that will affect brushing
- • Patients who were not willing to participate in the study
About Naksaka
Naksaka is a pioneering clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a commitment to enhancing patient outcomes, Naksaka specializes in the design and management of clinical trials across various therapeutic areas. Our team of experienced professionals collaborates closely with regulatory bodies, healthcare providers, and research institutions to ensure the highest standards of safety, efficacy, and compliance. By leveraging cutting-edge methodologies and a patient-centric approach, Naksaka aims to accelerate the delivery of groundbreaking therapies to market, ultimately improving the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Esenler, Turkey
Patients applied
Trial Officials
Nurcan Altas
Principal Investigator
Istanbul Medipol Univeristy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported